Day: May 5, 2022

AUM Biosciences Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate AUM001 in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer

Plan to conduct a global Phase 2 clinical trial to evaluate MNK inhibitor (AUM001) in combination with MSD’s anti-PD-1 therapy...

error: Content is protected !!